Table 4 Changes in chitotriosidase activity between basal and follow-up sampling, in relation to subjective symptoms and therapy adjustments during the observation period
From: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
Δ Chitotriosidase (nmol/ml/h) | p-value | |
|---|---|---|
Therapy modification | ||
• Improved (n = 47) | −64.5 ± 118.1 | 0.2045 |
• Stable (n = 164) | −1.3 ± 214.4 | 0.9389 |
• Worsened (n = 215) | 44.1 ± 131.4 | 0.0012 |